Tore Eid Selected Research

Temporal Lobe Epilepsy

1/2022	Oral glutamine supplementation increases seizure severity in a rodent model of mesial temporal lobe epilepsy.
1/2021	Network-Related Changes in Neurotransmitters and Seizure Propagation During Rodent Epileptogenesis.
1/2021	Astroglial Glutamine Synthetase and the Pathogenesis of Mesial Temporal Lobe Epilepsy.
1/2020	Circadian-Like Rhythmicity of Extracellular Brain Glutamate in Epilepsy.
11/2019	Astrocytes and Glutamine Synthetase in Epileptogenesis.
4/2019	Effects of Branched-Chain Amino Acid Supplementation on Spontaneous Seizures and Neuronal Viability in a Model of Mesial Temporal Lobe Epilepsy.
1/2019	Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.
2/2017	Progressive neuronal activation accompanies epileptogenesis caused by hippocampal glutamine synthetase inhibition.
1/2017	Network evolution in mesial temporal lobe epilepsy revealed by diffusion tensor imaging.
10/2015	Inhibition of glutamine synthetase in the central nucleus of the amygdala induces anhedonic behavior and recurrent seizures in a rat model of mesial temporal lobe epilepsy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tore Eid Research Topics

Disease

25	Temporal Lobe Epilepsy 01/2022 - 02/2002
20	Seizures (Absence Seizure) 01/2022 - 12/2002
17	Epilepsy (Aura) 03/2022 - 01/2008
5	Drug Resistant Epilepsy 04/2019 - 08/2006
3	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 11/2020
3	Partial Epilepsies (Epilepsy, Partial) 11/2021 - 07/2014
2	Neoplasms (Cancer) 01/2018 - 08/2017
2	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 04/2013
2	Sclerosis 02/2013 - 01/2004
2	Hippocampal Sclerosis 02/2013 - 08/2008
1	Brain Diseases (Brain Disorder) 01/2022
1	Hyperammonemia 11/2020
1	Hepatic Encephalopathy 11/2020
1	Liver Diseases (Liver Disease) 11/2020
1	Brain Edema (Cerebral Edema) 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 11/2019
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2018
1	Hypoxia (Hypoxemia) 12/2018
1	Pituitary ACTH Hypersecretion 01/2018
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Cognitive Dysfunction 01/2018
1	Necrosis 08/2017
1	Hypothermia 01/2016
1	Anhedonia 10/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2002
1	Ischemia 12/2002
1	Stroke (Strokes) 12/2002

Drug/Important Bio-Agent (IBA)

21	Glutamic Acid (Glutamate)FDA Link 01/2021 - 08/2006
15	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2022 - 01/2008
9	EnzymesIBA 01/2022 - 08/2006
7	Methionine SulfoximineIBA 01/2019 - 12/2009
6	Glutamine (L-Glutamine)FDA Link 01/2022 - 04/2013
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2016
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2008
3	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 07/2014
2	Therapeutic UsesIBA 01/2022 - 07/2014
2	Nicotine FDA Link 01/2022 - 08/2021
2	Amino Acids FDA Link 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 07/2014
2	AmmoniaIBA 11/2020 - 10/2015
2	Branched-Chain Amino AcidsIBA 04/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 01/2017
2	Glutamate DehydrogenaseIBA 01/2016 - 08/2006
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2016 - 01/2008
2	GlutaminaseIBA 01/2016 - 02/2007
1	Biological ProductsIBA 03/2022
1	PotassiumIBA 11/2020
1	Menthol FDA Link 11/2020
1	Valine (L-Valine)FDA Link 04/2019
1	Isoleucine (L-Isoleucine)FDA Link 04/2019
1	SolutionsIBA 04/2019
1	Leucine (L-Leucine)FDA Link 04/2019
1	Flurothyl (Flurotyl)IBA 01/2019
1	Kainic Acid (Kainate)IBA 01/2019
1	Pentylenetetrazole (Metrazol)IBA 01/2019
1	PicrotoxinIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	StrychnineIBA 01/2019
1	alpha-hydroxyglutarateIBA 12/2018
1	Insulin ReceptorIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2017
1	AntioxidantsIBA 08/2017
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2016
1	Sucrose (Saccharose)IBA 10/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2015
1	5-aminovaleric acidIBA 07/2014
1	LigandsIBA 04/2013
1	Hormones (Hormone)IBA 04/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	Potassium Channels (Potassium Channel)IBA 09/2012
1	Ketone BodiesIBA 01/2012
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 08/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2006
1	membrane-bound adrenal trypsin-like enzyme (MATLE)IBA 08/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2006
1	GABA Plasma Membrane Transport ProteinsIBA 04/2006
1	Butyric Acid (Butanoic Acid)IBA 04/2006
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2004
1	Retinaldehyde (Retinal)IBA 12/2002
1	AMPA Receptors (AMPA Receptor)IBA 02/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2008
1	Chronotherapy 01/2020
1	Ketogenic Diet 01/2015
1	Induced Hyperthermia (Thermotherapy) 11/2003